We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Quantifying disease progression in amyotrophic lateral sclerosis.
- Authors
Simon, Neil G.; Turner, Martin R.; Vucic, Steve; Al‐Chalabi, Ammar; Shefner, Jeremy; Lomen‐Hoerth, Catherine; Kiernan, Matthew C.
- Abstract
Amyotrophic lateral sclerosis (ALS) exhibits characteristic variability of onset and rate of disease progression, with inherent clinical heterogeneity making disease quantitation difficult. Recent advances in understanding pathogenic mechanisms linked to the development of ALS impose an increasing need to develop strategies to predict and more objectively measure disease progression. This review explores phenotypic and genetic determinants of disease progression in ALS, and examines established and evolving biomarkers that may contribute to robust measurement in longitudinal clinical studies. With targeted neuroprotective strategies on the horizon, developing efficiencies in clinical trial design may facilitate timely entry of novel treatments into the clinic. Ann Neurol 2014;76:643-657
- Publication
Annals of Neurology, 2014, Vol 76, Issue 5, p643
- ISSN
0364-5134
- Publication type
Article
- DOI
10.1002/ana.24273